Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 64, Issue 1, 2009, Pages 132-137

  Dalal, Mansi ^a   Ferrucci, Luigi ^b   Sun, Kai ^a   Beck, Justine ^a   Fried, Linda P ^a   Semba, Richard D ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c NONE   (United States)

Author keywords

Advanced glycation end products; Aging; Inflammation; Muscle; Sarcopenia

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; CAROTENOID; HEMOGLOBIN A1C; SELENIUM; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DISABILITY SEVERITY; DISEASE ASSOCIATION; FEMALE; GRIP STRENGTH; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MUSCLE WEAKNESS; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; WOMEN'S HEALTH; AGING; BLOOD; COMPARATIVE STUDY; DISABILITY; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

AGED; AGED, 80 AND OVER; AGING; DISABILITY EVALUATION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LYSINE; MUSCLE STRENGTH; MUSCLE WEAKNESS; PROGNOSIS; WOMEN'S HEALTH;

EID: 64249148929     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/gln018     Document Type: Article

References (44)

1. Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80-85. (Pubitemid 38090394)
2. Morley JE, Baumgartner RN, Roubenoff R, et al. Sarcopenia. J Lab Clin Med. 2001;137:231-243.
3. Carmeli E, Coleman R, Reznick AZ. The biochemistry of aging muscle. Exp Gerontol. 2002;37:477-489.
4. Doherty TJ. Aging and sarcopenia. J Appl Physiol. 2003;95:1717-1727.
5. Frontera WR, Hughes VA, Lutz KJ, et al. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol. 1991;71:644-650.
6. Visser M, Kritchevsky SB, Goodpaster BH, et al. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2002;50:897-904. (Pubitemid 34496688)
7. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889-896. (Pubitemid 34496687)
8. Wolfson L, Judge J, Whipple R, et al. Strength is a major factor in balance, gait, and the occurrence of falls. J Gerontol A Biol Sci Med Sci. 1995;50 (special issue): 64-67.
9. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-763. (Pubitemid 28183275)
10. Rantanen T, Volpato S, Ferrucci L, et al. Handgrip strength and causespecific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003;51:636-641. (Pubitemid 36541427)
11. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558-560. (Pubitemid 29081310)
12. Giampaoli S, Ferrucci L, Cecchi F, et al. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing. 1999;28:283-288. (Pubitemid 29229332)
13. Rantanen T, Harris T, Leveille SG, et al. Muscle strength and body mass index as long-term predictors of mortality in initially healthy men. J Gerontol A Biol Sci Med Sci. 2000;55:M168-M173. (Pubitemid 30243739)
14. Guallar-Castillón P, Sagardui-Villamor J, Banegas JR, et al. Waist circumference as a predictor of disability among older adults. Obesity (Silver Spring). 2007;15:233-244. (Pubitemid 46219804)
15. Zoico E, Di Francesco V, Guralnik JM, et al. Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women. Int J Obes Relat Metab Disord. 2004;28:234-241. (Pubitemid 38223504)
16. Semba RD, Blaum C, Guralnik JM, et al. Low carotenoid and vitamin E status are associated with indicators of sarcopenia among older women living in the community. Aging Clin Exp Res. 2003;15:482-487. (Pubitemid 38180786)
17. Beck J, Ferrucci L, Sun K, et al. Low serum selenium concentrations are associated with poor grip strength among older women living in the community. Biofactors. 2007;29:37-44. (Pubitemid 46985295)
18. Lauretani F, Semba RD, Bandinelli S, et al. Association of low plasma selenium concentrations with poor muscle strength in older community-dwelling adults: the InCHIANTI study. Am J Clin Nutr. 2007 ; 86:347-352. (Pubitemid 47256917)
19. Semba RD, Varadhan R, Bartali B, et al. Low serum carotenoids predict severe walking disability among older women living in the community. Age Ageing. 2007;36:62-67. (Pubitemid 46985295)
20. Payne GW. Effect of inflammation on the aging microcirculation: impact on skeletal muscle blood flow control. Microcirculation. 2006;13:343-352.
21. Goldberg T, Cai W, Peppa M, et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc. 2004;104:1287-1291. (Pubitemid 39036519)
22. Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis. 2007;196:9-21.
23. Haus JM, Carrithers JA, Trappe SW, et al. Collagen, cross-linking and advanced glycation endproducts in aging human skeletal muscle. J Appl Physiol. 2007;103:2068-2076.
24. Guralnik JM, Fried LP, Simonsick EM, et al. 1995. The Women's Health and Aging Study: Health and Social Characteristics of Older Women With Disability. Bethesda, MD: National Institute on Aging. NIH Publication No. 95-4009.
25. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
26. Reddy S, Bichler J, Wells-Knecht KJ, et al. N epsilon-(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry. 1995;34:10872-10878.
27. Boehm BO, Schilling S, Rosinger S, et al. Elevated serum levels of N e -carboxymethyl-lysine, an advanced glycation end product, are associated with proliferative diabetic retinopathy and macular oedema. Diabetologia. 2004;47:1376-1379. (Pubitemid 39232422)
28. Zhang X, Frischmann M, Kientsch-Engel R, et al. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients. Clin Chem Lab Med. 2005;43:503-511. (Pubitemid 41460627)
29. Sakurai S, Yamamoto Y, Tamei H, et al. Development of an ELISA for esRAGE and its application to type 1 diabetic patients. Diabetes Res Clin Pract. 2006;73:158-165. (Pubitemid 43928158)
30. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 9 (suppl 4): 2001;228S-233S.
31. Snow LM, Fugere NA, Thompson LV. Advanced glycation end-product accumulation and associated protein modification in type II skeletal muscle with aging. J Gerontol A Biol Sci Med Sci. 2007;62:1204-1210.
32. Schram MT, Schalkwijk CG, Bootsma AH, et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes. The EURODIAB prospective complications study. Hypertension. 2005;46:232-237.
33. Vashishth D, Gibson GJ, Khoury JI, et al. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001;28:195-201. (Pubitemid 32140975)
34. Hernandez CJ, Tang SY, Baumbach BM, et al. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycationmediated collagen cross-links. Bone. 2005;37:825-832.
35. Tang SY, Zeenath U, Vashishth D. Effects of non-enzymatic glycation on cancellous bone fragility. Bone. 2007;40:1144-1151. (Pubitemid 46386561)
36. O'Brien J, Morrissey PA. Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr. 1989;28:211-248.
37. Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A. 1997;94:6474-6479. (Pubitemid 27270709)
38. Vlassara H, Palace MR. Diabetes and advanced glycation end-products. J Intern Med. 2002;251:87-101.
39. Negrean M, Stirban A, Stratmann B, et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2007;85:1236-1243. (Pubitemid 46740464)
40. Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002;99:15596-15601. (Pubitemid 35403978)
41. Cai W, He JC, Zhu L, et al. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol. 2007;170:1893-1902. (Pubitemid 47339263)
42. Challier M, Jacqueminet S, Benabdesselam O, et al. Increased serum concentrations of soluble receptor for advanced glycation end-products in patients with type 2 diabetes. Clin Chem. 2005;51:1749-1750. (Pubitemid 41233122)
43. Nakamura K, Yamagishi S, Adachi H, et al. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev. 2007;23:368-371. (Pubitemid 47091239)
44. Kalousová M, Hodková M, Kazderová M, et al. Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis. 2006;47:406-411. (Pubitemid 43255173)